To further investigate the relationship between the FcγRIIB and immune evasion, we measured the IL-4 expression in serum and FcγRIIB expression of interstitial tissue cells in tumor tissues from the 12 cases of gastric cancer patients (6 from Immunotherapy sensitive group and 6 from Immunotherapy resistant group). The gene discussed is FCGR2B; the disease is gastric cancer.